Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis. - Aragón*, Carlota Abbad-Jaime de; Berna-Rico*, Emilio; Goas, Almudena; Pérez-Bootello, Javier; Ballester-Martinez, María Asunción; Jaén, Pedro; Blauvelt, Andrew; González-Cantero, Álvaro (Clinical & Experimental Dermatology, 2024)